Clinical trial
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With…
NCT00001332 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001332 |
|---|---|
| Title | Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis |
| Official title | Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Peritoneal Neoplasms, Stomach Neoplasms |
| Intervention type | Procedure |
| Interventions | CHPP with cisplatin |
| Enrollment | 50 |
| Start date | Dec 1, 1992 |
| Completion | Oct 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: